AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Managing Infectious Disease Burden by Unlocking the CBC: Role of Quantitative Measures of Monocytes in Response to Infection

  • Credit:1.5 ACCENT
  • Duration: 1.5 Hour
  • Date:SEP.28.2021 12:00 p.m. - 01:30 p.m.
  • Level: Intermediate

Price: $0.00

Member Price: $0.00

Rating: Member Average

This program was originally presented during the 2021 AACC Annual Scientific Meeting, held from September 26-30, 2021.

With your registration, you will have access to the recording on demand through September 30, 2022.


Sepsis, acute respiratory tract, and urinary tract infections, as well as COVID-19 are the most prevalent reasons for hospitalization of patients with infections. These conditions represent significant diagnostic and management challenges in the Emergency Department and may result in inappropriate use of antimicrobial agents, leading to poor patient outcomes. Collaboration between emergency medicine clinicians and laboratory professionals is key for the development of institutional protocols and practices incorporating both early identification and management of high-acuity infections. Faculty in this symposium will explore topics including severe infection and sepsis, current understanding of monocyte biology, and laboratory data and role of AI to improve patient outcomes.

Target Audience

This activity is designed for lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), point-of-care coordinators, pathologists, and other laboratory and healthcare professionals overseeing and/or carrying out topic.

Learning Objectives

At the end of this activity, participants will be able to:

  • Summarize the current challenges in the clinical assessment of severe infection and sepsis.
  • Incorporate new information on monocyte biology into decision-making in regard to assessing severe infection.
  • Describe the potential impact of laboratory data on patient outcomes as it relates to infectious disease management.



Anagh VoraAnagh Vora, MD
Chief Medical Officer
Senior Vice President, Medical and Scientific Affairs
Beckman Coulter
St. Louis, Missouri


Scott LevinScott Levin, PhD, MS
Associate Professor and Associate Director for Research, Emergency Medicine
Johns Hopkins Medicine
Baltimore, MD

Lael YonkerLael Yonker, MD
Pediatric Pulmonology, Director,
Massachusetts General Hospital Cystic Fibrosis Center
Principal Investigator, Pediatric COVID biorepository,
Mucosal Immunology and Biology Research Center,
Massachusetts General Hospital
Boston, Massachusetts

Disclosures and Statement of Independence

AACC is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported the following relevant financial relationship(s) during the content development process for this activity:

  • Anagh Vora, MD
    Salary: Beckman Coulter
  • Scott Levin, PhD, MS
    Stocks/Bonds: Danaher
    Intellectual Property/Royalty Income: IP from CDS technology leveraging MDW could be produced

The following faculty reported the no relevant financial relationship(s) during the content development process for this activity:

  • Lael Yonker, MD

Content Validity

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

Accreditation Statement

This activity is approved for 1.5 ACCENT® continuing education credits. Activity ID# 2167. This activity was planned in accordance with ACCENT® Standards and Policies.


Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].

Sponsored by

Beckman Coulter